Genomictree Company Description

Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases.

The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients.

It also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products.

The company was founded in 2000 and is headquartered in Daejeon, South Korea.

Genomictree Inc.

Country	South Korea
Founded	2000
Industry	In Vitro and In Vivo Diagnostic Substances
Employees	81
CEO	Sung-Whan An

Contact Details

Address: 44-6 Techno 10-ro Daejeon, 34027 South Korea
Phone	82 4 2861 4551
Website	genomictree.com

Stock Details

Ticker Symbol	228760
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2835

Key Executives

Name	Position
Sung-Whan An	Chief Executive Officer
Hong Sun Lee	Chief Financial Officer
Chi-Wang Yoon	Chief Operating Officer